Medical Research Future Fund (MRFF): Current Funding Opportunities

Medical Research Future Fund (MRFF): Current Funding Opportunities

12th February, 2020

New MRFF monthly newsletter – subscribe now!

The Health and Medical Research Office (Department of Health) will be releasing a monthly newsletter about the MRFF from January 2020. The Newsletter will provide the latest news and information about the MRFF, including open grant opportunities.

Subscribe to the MRFF monthly newsletter here.

 

Current and upcoming MRFF Funding Opportunities

See our summary below for current MRFF grant opportunities, open and closing dates for applications and how to apply. A list of recently closed application rounds is also available below.

In accordance with s24 of the Medical Research Future Fund Act 2015 , you must be one of the following bodies to be eligible for MRFF funding:

  • a medical research institute
  • a university
  • a corporate Commonwealth entity
  • a corporation (including businesses and not for profits).

Table 1

Grant and InitiativeApplicant type and purpose of initiativeManaging AgencyKey application datesHow to apply
Indigenous Health Research - Projects

GrantConnectID: GO3394

$13.5M
3 year projects up to $2M each

Part of the MRFF $160M 10 year Indigenous Health Research Fund
APPLICANT TYPE: multidisciplinary teams of researchers. Research should be led by Indigenous people and conducted through close engagement with Indigenous communities.

PURPOSE OF INITIATIVE:
To support practical, innovative health research into the best approaches to prevention, early intervention and treatment in one or more of the following areas:
- Ending avoidable blindness and deafness — Aboriginal and Torres Strait Islander people have a higher incidence of hearing and sight loss compared with non-Indigenous Australians
- Preventing chronic kidney disease — Aboriginal and Torres Strait Islander people experience approximately seven times the burden of disease due to chronic kidney disease than non-Indigenous Australians
- Improving adolescent mental health — Aboriginal and Torres Strait Islander adolescents experience significantly higher mortality rates compared with non-Indigenous Australians and experience a higher burden of disease from causes related to social and emotional wellbeing, including suicide.
NHMRC
Closes 12 February, 2020 5pm (AEDT)Apply through NHMRC's RGMS

Grant guidelines and other essential documents available on GrantConnect

Applications must be from NHMRC Administering Institutions
2019 Cardiovascular Health Grant Opportunity

GrantConnectID: GO3385

$12M

Part of the Cardiovascular Health Mission
OBJECTIVES:
- Improving prevention of heart disease and stroke
- Improved survival outcomes after an acute heart or stroke event through a focus on treatment
- Improving secondary prevention and survivorship after a cardiovascular event
NHMRC
Closes 12 February, 2020 5pm (AEDT)Apply through NHMRC's RGMS

Grant guidelines and other essential documents available on GrantConnect

Applications must be from NHMRC Administering Institutions
2019 Applied Artificial Intelligence Research in Health Grant

GrantConnect: GO3514

$7.5M
Part of the National Critical Research Infrastructure Initiative
OBJECTIVES:
- translate or implement innovative AI technologies into health applications that benefit multiple health disciplines/areas
- involve consumers in the research journey to ensure the research is applicable to the needs of the Australian community
- increase AI workforce capacity and capability, particularly in relation to health, through cross-sector and interdisciplinary collaboration.
Dept of Health (via the business.gov.au portal)Closes: 03 March, 2020 5pm (AEDT)


Apply through business.gov.au

Grant guidelines now available - see "Key Documents"
2019 Brain Cancer Survivorship Grant Opportunity

GrantConnect: GO3557

$5m
Part of the Australian Brain Cancer Mission
OBJECTIVES: to support the development of better approaches to address the medical, functional and psychosocial impacts of brain cancer to improve quality of life and the survivorship experience.Dept of Health (via the business.gov.au portal)Closes: 03 March, 2020 5pm (AEDT)Apply through business.gov.au

Grant guidelines now available - see "Key Documents"
Rural, Regional and Remote Clinical Trial Enabling Infrastructure Program

$100M

Part of the MRFF National Critical Infrastructure Initiative
APPLICANT TYPE: Eligible organisations seeking to deliver clinical trial infrastructure projects in rural, regional and remote areas of Australia.

PURPOSE OF INITIATIVE:
To remove barriers to participating in clinical trials by:
- Improving facilities, equipment, services and systems in rural, regional and remote Australia.
- Reducing the burden, costs and risks for patients and their families related to clinical trial participation.
- Increasing research capacity
Department of Health (via the business.gov.au portal)Closes 03 March, 2020 5pm (AEDT)Apply through business.gov.au

Grant guidelines now available - see "Key Documents"
2020 Stem Cell Therapies Grant Opportunity

GrantConnectID: GO3505

$6M

Part of the Stem Cell Therapies Mission
OBJECTIVES: to prime teams working on ‘proof of concept’ stem cell research targeted towards a health care outcome. Funding for such priming programs will target two priority areas aimed at driving innovation and accelerating implementation into clinical practice:
- Stem cell therapies
- New treatments using human tissues made from stem cells.
NHMRCCloses 04 March 2020 5pm (AEDT)Apply through NHMRC's RGMS

Grant guidelines and other essential documents available on GrantConnect

Applications must be from NHMRC Administering Institutions
2020 Traumatic Brain Injury Grant Opportunity

GrantConnectID: GO3523

$5M, estimated grant value $1M - $2M

Part of the Traumatic Brain Injury Mission



OBJECTIVES: to support clinical research that improves knowledge and its translation into practice in order to enhance personalisation of care after traumatic brain injury.
- identifying clinical biomarkers that are prognostic of outcomes
- novel imaging technologies and methods that could be used for prognostic purposes
- understanding genetic factors that impact outcomes
- investigating the novel use of artificial intelligence on administrative or other data collections to assist clinical decision making.
NHMRCCloses 04 March 2020 5pm (AEDT)

Minimum Data due 26 February 2020, 5pm (AEDT)
Apply through NHMRC's RGMS

Grant guidelines and other essential documents available on GrantConnect

Applications must be from NHMRC Administering Institutions
Frontier Health and Medical Research Initiative Stage One (Round Two)

10 grants between $250K and $1M to develop an initial research plan.
APPLICANT TYPE: research organisations

OBJECTIVES: to create opportunities for researcher collaborations to explore bold and innovative ideas in the health and medical research sector
Dept of Health (via the business.gov.au portal)
Closes 26 March, 2020 5pm (AEDT)
Applications will be through business.gov.au

Grant guidelines now available - see "Key Documents"
Biomedical Translation Bridge - Round 2


Up to $1 million in matching funding to nurture the translation of new therapies, technologies and medical devices through to the proof of concept stageMTPConnectOpens 17 February
Apply via the MTPConnect website

Guidelines, application templates and information slide deck and podcast available
Research for the novel coronavirus (COVID-19)

Announced via a media release on 18 Feb, 2020.

$2m available in an open and competitive grant opportunity.
This Grant Opportunity will complement the world-leading work already undertaken by the Doherty Institute, CSIRO and University of Queensland and their collaboration.Information will be available on GrantConnect.Opening date not announced yet.Guidelines and document will be available on GrantConnect.

 

Recently closed MRFF funding rounds

Table 2

MRFF InitiativeApplicant type and purpose of initiativeManaging AgencyClosing dateHow to apply
Global Health Initiative - 2019 Tackling AMR and DR-TB Grant Opportunity

GrantConnectID: GO3330

$8M
AIM: to support research that will enhance knowledge and develop tools to combat threats to national health security posed by the regional and global challenges of antimicrobial resistance and drug resistant tuberculosis through international research collaborationNHMRC
Closed 5 February, 2020Apply through NHMRC's RGMS

Grant guidelines and other essential documents available on GrantConnect

Applications must be from NHMRC Administering Institutions
2019 Endometriosis Research Grant Opportunity

GrantConnectID: GO3282

$9M over 5 years

Part of the MRFF Emerging Priorities and Consumer Driven Research (EPCDR) Initiative
APPLICANT TYPE: Australian researchers and research teams

PURPOSE OF INITIATIVE: To:
• facilitate innovative, high quality research that will lead to:
o improved diagnosis and treatment of endometriosis
o research that will address the gaps in research, leading to a better understanding of the causes and underlying factors that contribute to the development and progression of endometriosis
• facilitate consumer involvement in the design and evaluation of the research project (including participation in the conduct of the research)
• provide high-quality evidence for new health treatments and/or drugs (where appropriate)
• enable rapid translation of consumer-relevant research into clinical practice, health policy, and/or health advice that will lead to positive impacts for consumers
• encourage the development of multi-disciplinary research teams that deliver measureable outcomes that are a priority for consumers
• encourage collaboration between research teams, policy makers, healthcare funders and the health delivery sector (e.g. education, community, industry and/or healthcare).
NHMRCClosed 5 February, 2020Apply through NHMRC's RGMS

Grant guidelines, assessment scoring matrix and grant proposal template available on GrantConnect.

Applications must be from NHMRC Administering Institutions
2019 Ovarian Cancer Research Grant Opportunity

GrantConnectID: GO3286

$20M over 4 years

Part of the MRFF Emerging Priorities and Consumer Driven Research (EPCDR) Initiative
APPLICANT TYPE: Australian researchers and research teams

OBJECTIVES OF INITIATIVE:
• facilitate innovative, high quality research that will lead to:
o improved diagnosis and treatment of ovarian cancer
o research that will address the gaps in research, leading to a better understanding of the causes and underlying factors that contribute to the development and progression of ovarian cancer
• facilitate consumer involvement in the design and evaluation of the research project (including participation in the conduct of the research)
• provide high-quality evidence for new health treatments and/or drugs (where appropriate)
• enable rapid translation of consumer-relevant research into clinical practice, health policy, and/or health advice that will lead to positive impacts for consumers
• encourage the development of multi-disciplinary research teams that deliver measureable outcomes that are a priority for consumers
• encourage collaboration between research teams, policy makers, healthcare funders and the health delivery sector (e.g. education, community, industry and/or healthcare).
NHMRC
Closed 5 February, 2020Apply through NHMRC's RGMS

Grant guidelines, assessment scoring matrix and grant proposal template available on GrantConnect.

Applications must be from NHMRC Administering Institutions
2019 Neurological Disorders Clinical Trial Grant Opportunity

GrantConnectID: GO3230

$20M funding round as part of the MRFF Rare Cancers Rare Diseases and Unmet Need (RCRDUM) Initiative
APPLICANT TYPE: Australian research teams proposing one clinical trial

PURPOSE OF INITIATIVE:
To fund clinical trials that address a gap in current research and/or knowledge in neurological disorders, including (but not limited to) Duchenne Muscular Dystrophy (DMD), spinal cord injuries (SCI) and Autism Spectrum Disorders (ASD).

Applications must address the desired outcomes described in section 1.3 of the grant guidelines.
NHMRCClosed 5 February, 2020Apply through NHMRC's RGMS

Grant guidelines and other essential documents available on GrantConnect

Applications must be from NHMRC Administering Institutions
2019 Reproductive Cancers Clinical Trials Grant Opportunity

GrantConnectID: GO3227

$15M funding round as part of the MRFF Rare Cancers Rare Diseases and Unmet Need (RCRDUM) Initiative
APPLICANT TYPE: Australian research teams proposing one clinical trial

PURPOSE OF INITIATIVE:
To fund clinical trials that address a gap in current research and/or knowledge in reproductive cancers including:
- cancers of the cervix, uterus, vulva, fallopian tubes, endometrium or ovaries in women
- cancers of the testicles and penis in men.

Applications must address the desired outcomes described in section 1.3 of the grant guidelines.
NHMRCClosed 5 February, 2020Apply through NHMRC's RGMS

Grant guidelines and other essential documents available on GrantConnect
Guidelines updated 18/11 - grant scope no longer includes prostate cancer research (Guidelines v1.1)

Applications must be from NHMRC Administering Institutions
2019 Childhood Brain Cancer Clinical Trial Grant Opportunity

GrantConnectID: GO3232

$5M funding round as part of the MRFF Rare Cancers Rare Diseases and Unmet Need (RCRDUM) Initiative
APPLICANT TYPE: Australian research teams proposing one clinical trial

PURPOSE OF INITIATIVE:
To fund clinical trials that address a gap in current research and/or knowledge in childhood brain cancer.

Applications must address the desired outcomes described in section 1.3 of the grant guidelines.
NHMRCClosed 5 February, 2020Apply through NHMRC's RGMS

Grant guidelines and other essential documents available on GrantConnect

Applications must be from NHMRC Administering Institutions
2019 Rare Cancers, Rare Diseases and Unmet Need Clinical Trials Grant Opportunity

GrantConnectID: GO3228

$15M funding round as part of the MRFF Rare Cancers Rare Diseases and Unmet Need Initiative
APPLICANT TYPE: Australian research teams proposing one clinical trial

PURPOSE OF INITIATIVE:
To fund clinical trials that address a gap in current research and/or knowledge in rare cancers, rare diseases and areas of unmet medical need.

Applications must address the desired outcomes described in section 1.3 of the grant guidelines.
NHMRCClosed 5 February, 2020Apply through NHMRC's RGMS

Grant guidelines and other essential documents available on GrantConnect

Applications must be from NHMRC Administering Institutions
2019 Suicide Prevention Grant Opportunity

GrantConnectID: GO3283

$8M over 4 years

Part of the MRFF Million Minds Mission
APPLICANT TYPE: Australian researchers and research teams

PURPOSE OF INITIATIVE: The objectives of this grant opportunity are to:
• support innovative, high quality, collaborative research that focuses on interventions to prevent suicide
• promote effective translation of research into health policy and/or practice
• foster and build workforce capacity and workforce capability
• leverage collaborations between research teams, policy makers, healthcare funders and the health delivery sector (e.g. education, community, industry and/or healthcare)
NHMRCClosed 5 February, 2020Apply through NHMRC's RGMS

Grant guidelines, assessment scoring matrix and grant proposal template available on GrantConnect

Applications must be from NHMRC Administering Institutions
2019 Primary Health Care research

GrantID: GO3331

$5M as part of the Primary Health Care Research (PHCR) Initiative
OBJECTIVE:
The objective of this grant opportunity is to increase Australia’s evidence base in primary health care research for the following priority primary health care research topics:

- the provision of primary health care services in residential aged care and to older Australians in the community
- lessons from comprehensive primary health care service for Indigenous Australians for the broader primary health care system
- mental health service provision by general practice
- application of precision medicine and genomics in primary health care
- rural and regional access to services
- workforce issues, including scope of practice
- voluntary patient enrolment and blended payments
NHMRCClosed 5 February, 2020Apply through NHMRC's RGMS

Grant guidelines and other essential documents available on GrantConnect

Applications must be from NHMRC Administering Institutions
2019 Targeted Health System and Community Organisation Research Grant Opportunity

GrantConnectID: GO3328

$26M funding round as part of the the MRFF Preventive and Public Health Research (PPHR) Initiative
PURPOSE OF INITIATIVE:
Support research that addresses five questions developed by:
- Medical Services Advisory Committee (MSAC)
- Pharmaceutical Benefits Advisory Committee (PBAC)
- Prostheses List Advisory Committee (PLAC)
- Advisory Committee on Medical Devices (ACMD)
- Advisory Committee on Medicines (ACM) or
- The Medicare Benefits Review Taskforce (MBS Review Taskforce).

The five health system research question topics for this grant opportunity are:
1. Cancer treatment population
2. Tools to value health change in paediatric populations
3. Efficient use of high cost pharmaceuticals
4. Digital breast tomosynthesis
5. Circumcision revision
NHMRCClosed 5 February, 2020Apply through NHMRC's RGMS

Grant guidelines and other essential documents available on GrantConnect

Applications must be from NHMRC Administering Institutions
2019 Preventive and Public Health Research Grant Opportunity

To support research in:
- Maternal health & the first 2000 days
- Early childhood
- Exercise and nutrition


GrantConnectID: GO3326

$11.5M as part of the MRFF Preventive and Public Health Research (PPHR) Initiative
OBJECTIVES:
- foster new discoveries that lead to practice changes in community and clinical settings
- increase collaboration across academic disciplines, policy makers and health services to better understand the social, cognitive and emotional aspects of people’s health choices
- develop guidance, tools and interventions to support Australians to adopt positive behaviour change and to live active and healthy lives, and
- improve health outcomes for Australians living with chronic and complex disease through innovative public health approaches, particularly for Aboriginal and Torres Strait Islander peoples and for, disadvantaged regional and rural and culturally and linguistically diverse communities.
NHMRCClosed 5 February, 2020Apply through NHMRC's RGMS

Grant guidelines and other essential documents available on GrantConnect

Applications must be from NHMRC Administering Institutions
Pharmacogenomics to improve mental health treatment outcomes

GrantConnectID: GO3329

$7M as part of the Emerging Priorities and Consumer Driven Research (EPCDR) Initiative
OBJECTIVES:
- reduce barriers to clinical uptake of pharmacogenomics testing for patients presenting with neuropsychiatric conditions
- address gaps in evidence related to the application of pharmacogenomics for neuropsychiatric conditions
- encourage research that combines new or existing technologies with large-scale data, machine learning, clinical information, or patient biomarkers to develop new or refine existing tests that facilitate improved personalisation and efficacy of psychotropic medication regimens.
NHMRCClosed 5 February, 2020Apply through NHMRC's RGMS

Grant guidelines and other essential documents available on GrantConnect

Applications must be from NHMRC Administering Institutions
2020 Bushfire Impact Research Grant Opportunity

GrantConnectID: GO3529

$5M - Part of the MRFF Emerging Priorities and Consumer Driven Research (EPCDR) Initiative
OBJECTIVES:
Rapid response funding for research into the health effects of the bushfires:

- Stream 1 - address evidence gaps related to the physiological effects of prolonged exposure to the 2019-20 bushfire events and hazardous bushfire smoke.

- Stream 2 - address evidence gaps related to building mental health resilience following the 2019-20 bushfire events and exposure to hazardous bushfire smoke. into mental health effects on people in affected communities

Applications can address Stream 1 or Stream 2, or both.
NHMRCCLOSED 31 January, 2020Apply through NHMRC's RGMS

Grant guidelines available on GrantConnect
Targeted Health System and Community Organisation Research Grant Opportunity - Round 2

GrantConnect ID: GO2361
APPLICANT TYPE:
Australian research teams

OBJECTIVES:
Health system research topics:
1. Mobile X-ray services - residential aged care facilities
2. Health economics - impacts and costs associated with Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS)
NHMRCCLOSED 10 April, 2019Apply via NHMRC’s RGMS
International Clinical Trial Collaborations Grant Opportunity

2019 Round 1: closed

GrantConnect ID: GO1737

$42M over 4 years
Up to $4.2M per cycle
APPLICANT TYPE:
Australian research teams proposing a single clinical trial

OBJECTIVES:
• promote Australian involvement in international collaborative investigator-initiated clinical trials research
• provide evidence of the effectiveness of novel health treatments, drugs or devices that could then be used in Australia
NHMRC
ICT 2019 Round 1
CLOSED:
10 April, 2019


Continuous applications - 3 peer review cycles per year.
Information on how
to apply is available
on the NHMRC website.
Researcher Exchange and Development within Industry Initiative (REDI)

GrantConnect ID: GO2319

$32M over 4 years
APPLICANT TYPE:
A service provider who will facilitate connections between industry, universities, registered training organisations and government entities and deliver relevant training programs, industry placements, mentoring and exchange programs for researchers.

OBJECTIVES:
Strengthening Australia’s success with translation and commercialisation
Dept of Health (via the business.gov.au portal) CLOSED
9 April, 2019
Applications were submitted via https://www.business.gov.au/redi
Million Minds Mission Grant Opportunity

GrantConnect ID: GO2017

$25M over 5 years
APPLICANT TYPE: multidisciplinary teams of researchers

OBJECTIVES:
To fund research into:
• eating disorders
• mental health of children and young people
• mental health of Aboriginal and Torres Strait Islander peoples.
NHMRCCLOSED
20 February, 2019

Applications were submitted via NHMRC’s RGMS
Frontier Health and Medical Research Program Stage One – Research Plan

GrantConnect ID: GO1980





APPLICANT TYPE: research organisations

OBJECTIVES: to create opportunities for researcher collaborations to explore bold and innovative ideas in the health and medical research sector

A Stage One grant will form the basis of a Stage Two application. Up to 10 grants from $250K to $1M will be funded.
Dept of HealthCLOSED
26 February, 2019
Applications were submitted via https://www.business.gov.au/fhmr
Genomics Health Futures Mission - Project Grants Opportunity

GrantConnect ID: GO2473

GRANT SIZE: from $100K to $5M over 3 years
APPLICANT TYPE:
Australian researchers

ELIGIBLE ACTIVITIES:
- research and development
- disease modelling
- pre-clinical testing
- clinical trials.

OBJECTIVES:
for innovative and creative genomics research projects on:
1. cancers and diseases with high mortality and low survivability;
2. paediatric acute care genomic research for clinically ill children;
3. ethical, legal and social issues related to genomics in health care
Dept of Health (via the business.gov.au portal)CLOSED
31 May, 2019


First round - will run over 9 years (2019-20 to 2027-28)
Applications were submitted via business.gov.au/ghfmpg
BioMedTech Horizons - Round 2

$1 million of funding over a maximum two-year period
APPLICANT TYPE: for organisations to help progress medical technologies and devices through to Proof of Concept or beyond, the point where they are attractive to secure further venture capital or other funding.

OBJECTIVE: to support innovative collaborative health technologies, drive discoveries towards proof-of-concept and commercialisation that address key health challenges as well as maximise entrepreneurship and idea potential.
MTPConnectRound 2 - Successful EOIs will be announced 30 September, 2019.

ROUND 2 CLOSED 15 July, 2019
Expressions of Interest (EOIs) were submitted directly to MTPConnect.

Grant guidelines can be found here.
International Clinical Trial Collaborations Grant Opportunity

2019 Round 2

GrantConnect ID: GO1737

$42M over 4 years
Up to $4.2M per cycle
APPLICANT TYPE:
Australian research teams proposing a single clinical trial

OBJECTIVES:
• promote Australian involvement in international collaborative investigator-initiated clinical trials research
• provide evidence of the effectiveness of novel health treatments, drugs or devices that could then be used in Australia
NHMRCClosed 15 August, 2019

minimum data due 31 July, 2019

Continuous applications - 3 peer review cycles per year.

Information on how
to apply is available
on the NHMRC website.
Biomedical Translation Bridge ProgramOBJECTIVES: provides up to $1 million in matching funding to nurture the translation of new therapies, technologies and medical devices through to the proof of concept stage.MTPConnect, in partnership with BioCurate (University of Melbourne and Monash University), UniQuest (University of Queensland through its drug discovery initiative QEDDI), the Medical Device Partnering Program (MDPP, led by Flinders University), and the Bridge and BridgeTech programs (Queensland University of Technology)Closed 16 August, 2019.

Calls for Expressions Of Interest opened 1 July.
To submit an Expression of Interest, see MTPConnect's website

Guidelines available here
Genomics Health Futures Mission Flagships - Pathogen Genomics

GrantConnect ID: GO2481

GRANT SIZE: from $1M to $10M over 4 years
APPLICANT TYPE: Australian researchers/research teams

OBJECTIVES:
large-scale pilot research studies into pathogen genomics late in the research and development pipeline aiming to demonstrate clinical and/or public health utility, cost-effectiveness, and capacity for translation of genomics in the clinic, in recognition that such evidence is critical to the adoption of genomics in mainstream healthcare.
Dept of Health (via the business.gov.au portal) CLOSED 12 September, 2019
Applications were submitted via business.gov.au/pathogengenomics

See GrantConnect - Sample application forms available 16 July, grant guidelines updated 20 June
Accelerated Research - Congenital Heart Disease

GrantConnect ID: GO2511

GRANT SIZE: up to $10 million each over 5 years
APPLICANT TYPE: Australian researchers/research teams

OBJECTIVES:
Ideally projects will align with the National Strategic Action Plan for Childhood Heart Disease, and could target the Research Priorities in the Action Plan in particular:
* preventing neurodevelopmental and mental health complications
*understanding the impact of prenatal and postnatal factors affecting the health of children born with CHD and their families, or
*exploring the role of exercise and increased activity in reducing the impact of CHD.
Dept of Health (via the business.gov.au portal) CLOSED 12 September, 2019Applications were submitted via https://www.business.gov.au/chd
Researcher Exchange and Development within Industry Initiative (REDI)

GrantConnect ID: GO2827

$8 million in 2019-20
APPLICANT TYPE:
A service provider who will facilitate connections between industry, universities, registered training organisations and government entities and deliver relevant training programs, industry placements, mentoring and exchange programs for researchers.

This initiative has been reopened to allow tax exempt entities to apply.

OBJECTIVES:
Strengthening Australia’s success with translation and commercialisation
Department of Health (via the business.gov.au portal)CLOSED 5pm AEST 19 September, 2019Application wen to www.business.gov.au/redi

All applications already submitted will be assessed as part of this program unless an applicant advises otherwise - REDI@industry.gov.au
Medical Research Future Fund - Next Generation Clinical Researchers initiative
INVESTIGATOR GRANTS PRIORITY ROUND

GrantConnect ID: GO3039

Funding will be available to support applications commencing in both 2020 and 2021.
APPLICANT TYPE: Restricted to researchers applying at Emerging Leadership Level 1 and 2 (EL1 and EL2) Investigator Grants (see grant guidelines)

Applicants will also need to demonstrate how the grant will influence one or more of the following:
i. best practice clinical care;
ii. commercial health or medical research product/technology development;
iii. health policy;
iv. health system improvement.

Applicants who apply for an MRFF funded Investigator Grant will also be considered for an NHMRC Investigator Grant.

PURPOSE OF INITIATIVE: It will support the research program of outstanding early- to mid-career clinical researchers that contribute to the following MRFF priority research areas:

1. Australian Brain Cancer Mission
2. Million Minds Mission
3. Genomics Health Futures Mission
4. Ageing, Aged Care and Dementia Mission
5. Indigenous Health Research Fund
6. Stem Cell Therapies Mission
7. Mission for Cardiovascular Health
8. Traumatic Brain Injury Mission
9. Preventative and Public Health Research
10. Primary Health Care Research
11. Global Health – Tackling Antimicrobial Resistance and Drug Resistant Tuberculosis
NHMRC via NHMRC’s Investigator Grants 2020 scheme Closed 27 November, 2019Applications were submitted via NHMRC's RGMS portal (opens 2 October)

Grant guidelines now available (via "GO Documents" on GrantConnect)

MRFF - Next Generation Clinical Researchers initiative

Applicants who apply for an MRFF funded Investigator Grant will also be considered for an NHMRC Investigator Grant.
International Clinical Trial Collaborations Grant Opportunity

2019 Round 3

GrantConnect ID: GO1737

$42M over 4 years
Up to $4.2M per cycle
APPLICANT TYPE:
Australian research teams proposing a single clinical trial

OBJECTIVES:
• promote Australian involvement in international collaborative investigator-initiated clinical trials research
• provide evidence of the effectiveness of novel health treatments, drugs or devices that could then be used in Australia
NHMRCClosed 5pm AEDT 4 December, 2019

minimum data due 20 November, 2019

Continuous applications - 3 peer review cycles per year.
Information on how
to apply is available
on the NHMRC website.
BioMedTech Horizons

Round 3

$1 million of funding over a maximum two-year period
APPLICANT TYPE: for organisations to help progress medical technologies and devices through to Proof of Concept or beyond, the point where they are attractive to secure further venture capital or other funding.

OBJECTIVE: to support innovative collaborative health technologies, drive discoveries towards proof-of-concept and commercialisation that address key health challenges as well as maximise entrepreneurship and idea potential.
MTPConnectRound 3 closed 16 December, 2019 5pm AEDTApplicants applied here

Grant guidelines available here

For more information, see MTPConnect.